Loading...
HAL-Inserm est le portail Inserm de l'archive ouverte nationale qui permet le dépôt en ligne des travaux scientifiques et leur consultation.
Contact
Pour répondre au courrier de la Direction Générale, il est de la responsabilité de chaque chercheur Inserm de :
1-Déposer systématiquement les articles publiés à partir de 2020 dans HAL (quelque soit le portail),
2-Adjoindre obligatoirement au dépôt le fichier de l’article (voir l'aide au dépôt dans l'onglet "Informations pratiques").
Derniers dépôts
-
Miranda Fidler, Raoul Reulen, David Winter, Rodrigue Allodji, Francesca Bagnasco, et al.. Risk of Subsequent Bone Cancers Among 69 460 Five-Year Survivors of Childhood and Adolescent Cancer in Europe. JNCI: Journal of the National Cancer Institute, 2018, 110 (2), pp.183-194. ⟨10.1093/jnci/djx165⟩. ⟨inserm-04439808⟩
-
Nicolas Chausson, Stéphane Olindo, François-Xavier Laborne, Manvel Aghasaryan, Pauline Renou, et al.. Second-dose intravenous thrombolysis with tenecteplase in alteplase-resistant medium-vessel-occlusion strokes: A retrospective and comparative study. European Stroke Journal, 2024, Online ahead of print. ⟨10.1177/23969873241254936⟩. ⟨inserm-04602955⟩
-
Daniel Bertin, Pierre Bongrand, Nathalie Bardin. Comparison of the Capacity of Several Machine Learning Tools to Assist Immunofluorescence-Based Detection of Anti-Neutrophil Cytoplasmic Antibodies. International Journal of Molecular Sciences, 2024, 25 (6), pp.3270. ⟨10.3390/ijms25063270⟩. ⟨hal-04600596⟩
-
Robin Birus, Ehab El‐awaad, Laurens Ballentin, Faten Alchab, Dagmar Aichele, et al.. 4,5,7‐trisubstituted indeno[1,2‐ b ]indole inhibits CK2 activity in tumor cells equivalent to CX‐4945 and shows strong anti‐migratory effects. FEBS Open Bio, 2022, 12 (2), pp.394-411. ⟨10.1002/2211-5463.13346⟩. ⟨hal-03471998⟩
-
Claire Dahyot-Fizelier, Denis Frasca, Sigismond Lasocki, Karim Asehnoune, Dorothée Balayn, et al.. Prevention of early ventilation-acquired pneumonia (VAP) in comatose brain-injured patients by a single dose of ceftriaxone: PROPHY-VAP study protocol, a multicentre, randomised, double-blind, placebo-controlled trial. BMJ Open, 2018, 8 (10), pp.e021488. ⟨10.1136/bmjopen-2018-021488⟩. ⟨hal-02535525⟩
-
B. Drugeon, M. Pichon, N. Marjanovic, S. Mousse, S. Seguin, et al.. Peripheral venous catheter colonization after skin disinfection with 0.5% aqueous sodium hypochlorite, preceded or not by one application of 70% ethanol (DACLEAN): a single-centre, randomized, open-label, pilot study. Journal of Hospital Infection, 2022, 120, pp.123-126. ⟨10.1016/j.jhin.2021.11.012⟩. ⟨hal-03615774⟩